Literature DB >> 11004561

Characterization of yeast seryl-tRNA synthetase active site mutants with improved discrimination against substrate analogues.

I Landeka1, S Filipic-Rocak, B Zinic, I Weygand-Durasevic.   

Abstract

The involvement of amino acids within the motif 2 loop of Saccharomyces cerevisiae seryl-tRNA synthetase (SerRS) in serine and ATP binding was demonstrated previously [B. Lenhard et al., J. Biol. Chem. 272 (1997) 1136-1141]. In our attempt to analyze the structural basis for the substrate specificity and to explore further the catalytic mechanism employed by S. cerevisiae SerRS, two new active site mutants, SerRS11 and SerRS12, were constructed. The catalytic effects of amino acid replacement at positions Lys287, Asp288 and Ala289 with purified wild-type and mutant seryl-tRNA synthetases were tested. The alteration of these semi-conserved amino acids interferes with tRNA-dependent optimization of serine recognition. Additionally, mutated enzymes SerRS11 (Lys287Thr, Asp288Tyr, Ala289Val) and SerRS12 (Lys287Arg) are less sensitive to inhibition by two competitive inhibitors: serine hydroxamate, an analogue of serine, and 5'-O-[N-(L-seryl)-sulfamoyl]adenosine, a stable analogue of aminoacyl adenylate, than the wild-type enzyme. SerRS mutants also display different activation kinetics for serine and serine hydroxamate, indicating that specificity toward the substrates is modulated by amino acid replacement in the motif 2 loop.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004561     DOI: 10.1016/s0167-4838(00)00066-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development.

Authors:  Wiebke Herzog; Katja Müller; Jan Huisken; Didier Y R Stainier
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

2.  An orthogonal seryl-tRNA synthetase/tRNA pair for noncanonical amino acid mutagenesis in Escherichia coli.

Authors:  Claudio Zambaldo; Minseob Koh; Fariborz Nasertorabi; Gye Won Han; Abhishek Chatterjee; Raymond C Stevens; Peter G Schultz
Journal:  Bioorg Med Chem       Date:  2020-07-28       Impact factor: 3.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.